*

16/05/2018

 |  |  |  |  |   |   |   |  | 

ODA | RDA |  |   |   |   | 

 

. , , .
. ( ), ; , (1).
(1)  (Food and Drug Administration).
, (GH), (2).
(3). , () , , (4). , ( ) (5).
(Nitric Oxide) , , : (1,2), 2, , , , , (1).
, , , (4) (6). . , (3), (1).
.

 

, , , , , , , , , , , , ', , , , , (6).
:  ( ), , , (6).

 

  • –  (nitric oxide synthase) (3,6).
  • (urea) –  , , (3,6).
  •   , (3).
  • (3) –  (3).
  •   , (6), , (4).
  • (6,5) –  (7).

 

(8-10), (6,11-15), (7,16,17), (18), (2,19,20), 2(21,22), (1,6,23,24), (1,25), (6,26),   (1,27,28) (HHH-Syndrome).

 


.
34 , . ,    
.
40 ,    

 


. . (6).
50 . 6    

 


, , . (6)  (immunostimulant). . .
.    

 


, . , , . , , , .
16 72-85 , 3    

 


(2,19). (2). , (20).
33 2 . ,    

 

2
2 . . - 2    

 


, , .
.
, , (23).
, :    

 


. 8 . . 6 .    

 


, (6).
Acetazolamide .    

 

(HHH-Syndrome)
, . (27)  (Hyperammonemia), (Hyperornithinemia) (Homocitrullinuria). , (28).
   

 

  •      
  •      
  • –     
  • –     
  • (Body Building) –     
  • –  2    
  •      
  • (GH) –  -FDA    
  •      
  •     

 

. (5).
(nitric oxide synthases) (Nitric-Oxid)  - (L-Citrulline).
, , ,    
, ,    
   
. , .    

 

  •   ,    
  • 2 –     
  • –     
  • –     
  •      
  • –     
  •      
  • –  , , ,    
  • –     
  • –     

 

,    

 

()

   
   
   

,    

 

-RDA

-RDA.

 

-ODA

-ODA.

 


   

 


. 2 -100 (5).    
     
–     
     
–  '    
   
–     
     
     
–     
–       
     

 

 |  |  |   |   |  |  |  |  | NAC |  |  |  |  C |  | 

 


, .
.
(53).
44 CHOP, (Cyclophosphamide), (Hydroxydaunorubicin), (Oncovine) (Prednisone).
   
 

(Cyclosporine) 
.
. .
. (55):

10    

 

Phosphodiesterase-5 (, Sildenafil)
Phosphodiesterase-5 ( : PDE-5), .
, Sildenafil ().
116 , , .    

 

( ACE, )
, .
, .
, . ACE .  , , (1,6)
, ,    

 


, .
, . , (). , .
, (1,6,20,22,59,63-69).
24 2 ,    

 

(Nitrates)
, .
.
, , (23).
. 14 . (isosorbide mononitrate) .    

 

Pausinystalia johimbe (, yohimbine)
.
, yohimbine, (6).
45 .  .    

 

(Pycnogenol, Prelox)
.
Pycnogenol, , (NO), , .
, , , , .
, 3 , 25-45 . ,    

 

(Ornithine)
.
(GH), , (6). , (body building).
. -50% (6).
(    

 

N-acetyl cysteine (- – NAC)
N-acetyl cysteine.
24 2 . , .    

 

Ibuprofen –
.
, ibuprofen arginate,    

 

()
.
   

 


.
Isoniazid, Pyrazinamide, Rifampicin -Streptomycin Ethambutol    

 

C

.
C .
28 C (). : (Saline) 2 ,    
 

(L-Lysine)
.
108    

 

Pentoxifylline –
, .
,    

 

 


,    

 

(L-Lysine)
(6).
, (6).
   

 

 –  ,    
 –  , .    
 – (6).
 –    
 – ,    
 – . ,    
 – ,    
 – (1). ,    

 

(2015) . ,  DASH  -, . , , , , , ,   .    

(2015) , , .

,    

(2015) 75 ,  . () '  Panax ginseng), Agrimonia pilosa, Thlaspi arvense) .    

(2015) -    

 

(2015)    

 

- (2015) . 50     ( ),    roburins - -, .    

(2015) 25 ( ) . 72   3 : 25 , + 1.6 . 28 6 . 25    

 

-2014   - , -, - ( ) . 50 2 ,  wash out, -cross over  . , , , , .    

 

(2014)  ,  .    

 

- (2014) - . 11 321 -    

 

2014 , ,    . 136 6 , 15 . , ',   ,  -.

   

 

  . . (2013)  . 4 -9 .    

 

 


  1. Naturastandard.com. Arginin. Available here.
  2. Jade Teta, ND, CSCS, and Keoni Teta, ND, LAc, CSCS Sports NutritionTextbook of Natural Medicine 2013 4th ed.Page 536
  3. Examine.com - Arginine
  4. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998 Nov 15;336 ( Pt 1):1-17.
  5. YVETTE C. LUIKING, LETICIA CASTILLO, AND NICOLAAS E.P. DEUTZ Arginine, Citrulline, andNitric Oxide Modern Nutrition in Health and Disease 11Th Ed-2.
  6. Mitchell Stargrove, Jonathan Treasure, Dwight McKee, Herb, Nutrient, and Drug Interactions Pages 2007 December 653-660
  7. Kirk, S. J., Hurson, M., Regan, M. C., Holt, D. R., Wasserkrug, H. L., and Barbul, A. Arginine stimulates wound healing and immune function in elderly human beings. Surgery 1993;114(2):155-159
  8. Cesare Battaglia, Michela Salvatori, Nicoletta Maxia, Felice Petraglia, Fabio Facchinetti and Annibale Volpe. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Oxford Journals Medicine & Health Human Reproduction Volume 14 Issue 7 Pp. 1690-1697.
  9. Scibona, M., Meschini, P., Capparelli, S., Pecori, C., Rossi, P., and Menchini Fabris, G. F. [L-arginine and male infertility]. Minerva Urol.Nefrol. 1994;46(4):251-253
  10. Pryor, J. P., Blandy, J. P., Evans, P., Chaput De Saintonge, D. M., and Usherwood, M. Controlled clinical trial of arginine for infertile men with oligozoospermia. Br J Urol. 1978;50(1):47-50
  11. Hartmut Glossmann, , Günther Petrischor, Georg Bartsch. Molecular mechanisms of the effects of sildenafil (VIAGRA®) Experimental Gerontology Volume 34, Issue 3, June 1999, Pages 305–318
  12. J. CHEN, Y. WOLLMAN, T. CHERNICHOVSKY, A. IAINA, M. SOFER and H. MATZKIN Effect of oral administration of high-dose nitric oxide donor l-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study BJU International (1999), 83, 269–273 
  13. Lebret T, Herve JM, Gorny P et al. Efficacy and safety of a novel combination of l-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Eur Urol 2002;41:608-613; discussion 613
  14. Stanislavov, R. and Nikolova, V. Treatment of erectile dysfunction with pycnogenol and L-arginine. J Sex Marital Ther 2003;29(3):207-213
  15. Ledda, A., Belcaro, G., Cesarone, M. R., Dugall, M., and Schonlau, F. Investigation of a complex plant extract for mild to moderate erectile dysfunction in a randomized, double-blind, placebo-controlled, parallel-arm study. BJU.Int. 2010;106(7):1030-1033
  16. Cen Y, Luo XS, Liu XX. Effect of L-arginine supplementation on partial-thickness burned patients. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 1999 Jul;13(4):227-31.
  17. Debats, I. B., Booi, D. I., Wehrens, K. M., Cleutjens, J., Deutz, N. E., van de Hogen, E., Bemelmans, M., and van der Hulst, R. R. Oral arginine supplementation and the effect on skin graft donor sites: a randomized clinical pilot study. J Burn Care Res 2009;30(3):417-426
  18. Yoshinori Ohtsuka, MD, PhD, Jun Nakaya, MD, PhD Effect of oral administration of L-arginine on senile dementia April 1, 2000Volume 108, Issue 5, Page 439
  19. McKnight JR, Satterfield MC, Jobgen WS, Smith SB, Spencer TE, Meininger CJ, McNeal CJ, Wu G. Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health. Amino Acids. 2010 Jul;39(2):349-57.
  20. Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fermo I, Rabaiotti G, Gatti R, Piatti P. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E906-12. Epub 2006 Jun 13.
  21. Lubec, B., Hayn, M., Kitzmüller, E. et al. L-arginine reduced lipid peroxidation in patients with diabetes mellitus. Free Rad Biol Med. 1997; 22: 355–357
  22. Wascher, T. C., Graier, W. F., Dittrich, P., Hussain, M. A., Bahadori, B., Wallner, S., and Toplak, H. Effects of low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity. Eur.J Clin.Invest 1997;27(8):690-695
  23. Judy WM Cheng and Stephen N Balwin L-Arginine in the Management of Cardiovascular DiseasesThe Annals of Pharmacotherapy ■ 2001 June, Volume 35
  24. Stéphane Doutreleau, Olivier Rouyer, Paola Di Marco, Evelyne Lonsdorfer, Ruddy Richard, François Piquard, and Bernard Geny. L-Arginine supplementation improves exercise capacity after a heart transplant6th Amino Acid Assessment Workshop 2010 American Society for Nutrition
  25. Bortolotti M , Brunelli F , Sarti P , Miglioli M Clinical and manometric effects of L-arginine in patients with chest pain and oesophageal motor disorders. Italian Journal of Gastroenterology and Hepatology [1997, 29(4):320-324]
  26. Heble DE Jr, Oschman A, Sandritter TL. Comparison of Arginine Hydrochloride and Acetazolamide for the Correction of Metabolic Alkalosis in Pediatric Patients. Am J Ther. 2014 Nov 6.
  27. Martinelli D, Diodato D, Ponzi E, Monné M, Boenzi S, Bertini E, Fiermonte G, Dionisi-Vici C. The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Orphanet J Rare Dis. 2015 Mar 11;10:29. doi: 10.1186/s13023-015-0242-9
  28. Mhanni AA, Chan A, Collison M, Seifert B, Lehotay DC, Sokoro A, Huynh HQ, Greenberg CR. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH) presenting with acute fulminant hepatic failure. J Pediatr Gastroenterol Nutr. 2008 Mar;46(3):312-5.
  29. Steven P. Schulman, MD; Lewis C. Becker, MD; David A. Kass, MD; Hunter C. Champion, MD, PhD; Michael L. Terrin, MD; Sandra Forman, MA; Kavita V. Ernst, MD; Mark D. Kelemen, MD; Susan N. Townsend, RN, BS; Anne Capriotti; Joshua M. Hare, MD; Gary Gerstenblith, MD L-Arginine Therapy in Acute Myocardial Infarction The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) Randomized Clinical Trial JAMA. 2006;295(1):58-64.
  30. Helmut Drexler, Burkhard Hornig Endothelial Dysfunction in Human Disease Journal of Molecular and Cellular Cardiology Volume 31, Issue 1, January 1999, Pages 51–60
  31. Chauhan A, More RS, Mullins PA, Tayor G, Petch MC, Schofield PM. Aging-associated endothelial dysfunction in humans is reversed by L-arginine.J Am Coll Cardiol. 1996;28:1796-1804
  32. Guttman, H., Zimlichman, R., Boaz, M., Matas, Z., and Shargorodsky, M. Effect of Long-Term L-Arginine Supplementation on Arterial Compliance and Metabolic Parameters in Patients with Multiple Cardiovascular risk Factors: Randomized, Placebo-Controlled Study. J Cardiovasc.Pharmacol. 6-7-2010
  33. Giugliano, D., Marfella, R., Verrazzo, G., Acampora, R., Coppola, L., Cozzolino, D., and D'Onofrio, F. The vascular effects of L-Arginine in humans. The role of endogenous insulin. J Clin.Invest 2-1-1997;99(3):433-438
  34. Sozykin, A. V., Noeva, E. A., Balakhonova, T. V., Pogorelova, O. A., and Men'shikov, M. I. [Effect of L-arginine on platelet aggregation, endothelial function adn exercise tolerance in patients with stable angina pectoris]. Ter.Arkh. 2000;72(8):24-27 
  35. Bode-Boger, S. M., Boger, R. H., Creutzig, A., Tsikas, D., Gutzki, F. M., Alexander, K., and Frolich, J. C. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin.Sci.(Lond) 1994;87(3):303-310Adams, M. R., Forsyth, C. J., Jessup, W., Robinson, J., and Celermajer, D. S. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J Am Coll.Cardiol 1995;26(4):1054-1061 
  36. Marfella, R., Acampora, R., Verrazzo, G., Ziccardi, P., De, Rosa N., Giunta, R., and Giugliano, D. Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients. Diabetes Care 1996;19(9):934-939Wolf, A., Zalpour, C., Theilmeier, G., Wang, B. Y., Ma, A., Anderson, B., Tsao, P. S., and Cooke, J. P. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll.Cardiol 3-1-1997;29(3):479-485 
  37. Marietta, M., Facchinetti, F., Neri, I., Piccinini, F., Volpe, A., and Torelli, G. L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release. Thromb.Res 10-15-1997;88(2):229-235 
  38. Siani, A., Pagano, E., Iacone, R., Iacoviello, L., Scopacasa, F., and Strazzullo, P. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens. 2000;13(5 Pt 1):547-551
  39. Margaret E. Brosnan and John T. Brosnan Orotic Acid Excretion and Arginine Metabolism The Journal of Nutrition 
  40. de Jonge WJ, Hallemeesch MM, Kwikkers KL, Ruijter JM, de Gier-de Vries C, van Roon MA, Meijer AJ, Marescau B, de Deyn PP, Deutz NE, Lamers WH. Overexpression of arginase I in enterocytes of transgenic mice elicits a selective arginine deficiency and affects skin, muscle, and lymphoid development. Am J Clin Nutr. 2002 Jul;76(1):128-40.
  41. J. F. Reckelhoff, J. A. Kellum Jr, L. C. Racusen, D. A. Hildebrandt Long-term dietary supplementation with L-arginine prevents age-related reduction in renal function American Journal of Physiology - Regulatory, Integrative and Comparative Physiology Published 1 June 1997 Vol. 272 no. 6, R1768-R1774 DOI:
  42. Drover, J. W., Dhaliwal, R., Weitzel, L., Wischmeyer, P. E., Ochoa, J. B., and Heyland, D. K. Perioperative use of arginine-supplemented diets: a systematic review of the evidence. J Am.Coll.Surg. 2011;212(3):385-99, 399.
  43. Park KG. The Sir David Cuthbertson Medal Lecture 1992. The immunological and metabolic effects of l-arginine in human cancer. Proc Nutr Soc 1993;52:387-401
  44. Vincenzo Bronte & Paola Zanovello Regulation of immune responses by L-arginine metabolism Nature Reviews Immunology 5, 641–654 (1 August 2005)
  45. Nelson, R. L., Thomas, K., Morgan, J., and Jones, A. Non surgical therapy for anal fissure. Cochrane.Database.Syst.Rev. 2012;2:CD003431
  46. Pezza V, Bernardini F, Pezza E, Pezza B, Curione M. Study of supplemental oral l-arginine in hypertensives treated with enalapril + hydrochlorothiazide. Am J Hypertens. 1998 Oct;11(10):1267-70.
  47. Lucotti, P., Monti, L., Setola, E., La, Canna G., Castiglioni, A., Rossodivita, A., Pala, M. G., Formica, F., Paolini, G., Catapano, A. L., Bosi, E., Alfieri, O., and Piatti, P. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism 2009;58(9):1270-1276
  48. Rector, T. S., Bank, A. J., Mullen, K. A., Tschumperlin, L. K., Sih, R., Pillai, K., and Kubo, S. H. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 6-15-1996;93(12):2135-2141 
  49. Bednarz, B., Jaxa-Chamiec, T., Gebalska, J., Herbaczynska-Cedro, K., and Ceremuzynski, L. L-arginine supplementation prolongs exercise capacity in congestive heart failure. Kardiol.Pol. 2004;60(4):348-353
  50. Fontanive, P., Saponati, G., Iurato, A., Volterrani, C., Boni, A., Piccioni, L., and Dini, F. L. Effects of L-arginine on the Minnesota Living with Heart Failure Questionnaire quality-of-life score in patients with chronic systolic heart failure. Med.Sci.Monit. 2009;15(12):CR606-CR611
  51. Sydow, K., Schwedhelm, E., Arakawa, N., Bode-Boger, S. M., Tsikas, D., Hornig, B., Frolich, J. C., and Boger, R. H. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. Cardiovasc.Res 2003;57(1):244-252
  52. Maxwell, A. J., Anderson, B. E., and Cooke, J. P. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc.Med. 2000;5(1):11-19
  53. Brittenden J, Heys SD, Eremin O.l-Arginine and malignant disease: a potential therapeutic role? Eur J Surg Oncol 1994;20:189-192.
  54. Brittenden J, Heys SD, Miller I et al. Dietary supplementation withl-arginine in patients with breast cancer (>4 cm) receiving multimodality treatment: report of a feasibility study. Br J Cancer 1994;69:918-921.
  55. Zhang XZ, Ardissino G, Ghio L, Tirelli AS, Daccò V, Colombo D, Pace E, Testa S, Claris-Appiani A. L-arginine supplementation in young renal allograft recipients with chronic transplant dysfunction. Clin Nephrol. 2001 Jun;55(6):453-9.
  56. Andrés A1, Morales JM, Praga M, Campo C, Lahera V, García-Robles R, Rodicio JL, Ruilope LM. L-arginine reverses the antinatriuretic effect of cyclosporin in renal transplant patients. Nephrol Dial Transplant. 1997 Jul;12(7):1437-40.
  57. Andoh, Takeshi F.; Gardner, Michael P.; Bennett, William M. PROTECTIVE EFFECTS OF DIETARY L-ARGININE SUPPLEMENTATION ON CHRONIC CYCLOSPORINE NEPHROTOXICITY1 Transplantation:15 November 1997 - Volume 64 - Issue 9 - pp 1236-1240
  58. Alexander JW, Levy A, Custer D et al. Arginine, Fish Oil, and Donor-Specific Transfusions Independently Improve Cardiac Allograft Survival in Rats Given Subtherapeutic Doses of Cyclosporin. JPEN J Parenter Enteral Nutr May 1998 vol. 22 no. 3 152-155.
  59. JongUn Lee, Soo Wan Kim, Hyun Kook, Dae Gill Kang, Nam Ho Kim and Ki Chul Choi Effects of L-arginine on cyclosporin-induced alterations of vascular NO/cGMP generation Oxford Journals Medicine & Health Nephrology Dialysis Transplantation Volume 14 Issue 11 Pp. 2634-2638
  60. Mantovani F, Patelli E, Colombo F, Pozzoni F, Confalonieri S, Pisani E Erectile dysfunction after non-nerve sparing radical pelvic surgery. Therapeutical experience with sildenafil and L-arginine evaluated by Buckling test stituto di Urologia, IRCCS Ospedale Maggiore, Milan, Italy.Minerva Medica [2001, 92(4):285-287]
  61. Komers, R., Komersova, K., Kazdova, L., Ruzickova, J., and Pelikanova, T. Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to L-arginine in humans. J Hypertens. 2000;18(1):51-59.
  62. Martina, V., Masha, A., Gigliardi, V. R., Brocato, L., Manzato, E., Berchio, A., Massarenti, P., Settanni, F., Della, Casa L., Bergamini, S., and Iannone, A. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 2008;31(5):940-944
  63. McConell, G. K., Huynh, N. N., Lee-Young, R. S., Canny, B. J., and Wadley, G. D. L-Arginine infusion increases glucose clearance during prolonged exercise in humans. Am J Physiol Endocrinol.Metab 2006;290(1):E60-E66
  64. Piatti, P. M., Monti, L. D., Valsecchi, G., Magni, F., Setola, E., Marchesi, F., Galli-Kienle, M., Pozza, G., and Alberti, K. G. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 2001;24(5):875-880. 
  65. Bello, E., Caramelo, C., Martell, N., Alcazar, J. M., Gonzalez, J., Lopez, M. D., Ruilope, L. M., Gonzalez, F. R., Rovira, A. M., Gazapo, R., Soldevilla, M. J., and Casado, S. Impairment of renal vasodilation with l-arginine is related to more severe disease in untreated hypertensive patients. Hypertension 2001;38(4):907-912 
  66. Paolisso, G., Tagliamonte, M. R., Marfella, R., Verrazzo, G., D'Onofrio, F., and Giugliano, D. L-arginine but not D-arginine stimulates insulin-mediated glucose uptake. Metabolism 1997;46(9):1068-1073 
  67. Stokes, G. S., Barin, E. S., Gilfillan, K. L., and Kaesemeyer, W. H. Interactions of L-arginine, isosorbide mononitrate, and angiotensin II inhibitors on arterial pulse wave. Am J Hypertens. 2003;16(9 Pt 1):719-724.
  68. Elam RP. Morphological changes in adult males from resistance exercise and amino acid supplementation. J Sports Med Phys Fitness 1988;28:35-39
  69. Elam RP, Hardin DH, Sutton RA, Hagen L. Effects of arginine and ornithine on strength, lean body mass and urinary hydroxyproline in adult males. J Sports Med Phys Fitness 1989;29:52-56
  70. Black P, Max MB, Desjardins P, Norwood T, Ardia A, Pallotta T. A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain. Clin Ther. 2002 Jul;24(7):1072-89.
  71. Mehlisch DR, Ardia A, Pallotta T. A controlled comparative study of ibuprofen arginate versus conventional ibuprofen in the treatment of postoperative dental pain. J Clin Pharmacol. 2002 Aug;42(8):904-11
  72. Donald R Mehlisch, MD, DDS, Alfredo Ardia, PhD, and Teresa Pallotta, PhD Analgesia with ibuprofen arginate versus conventional ibuprofen for patients with dysmenorrhea: a crossover trial Curr Ther Res Clin Exp. 2003 Jun; 64(6): 327–337.
  73. Schulze, F., Glos, S., Petruschka, D., Altenburg, C., Maas, R., Benndorf, R., Schwedhelm, E., Beil, U., and Boger, R. H. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides
  74. Schon, T. et al. (2003) Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. Eur. Respir. J. 21, 483–488
  75. Tousoulis, D., Xenakis, C., Tentolouris, C., Davies, G., Antoniades, C., Crake, T., and Stefanadis, C. Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina. Heart 2005;91(10):1319-1323
  76. Schlaich, M. P., Oehmer, S., Schneider, M. P., Delles, C., Schmidt, B. M., and Schmieder, R. E. Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk. Atherosclerosis 2007;192(1):155-160
  77. Smriga, M., Ando, T., Akutsu, M., Furukawa, Y., Miwa, K., and Morinaga, Y. Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans. Biomed.Res 2007;28(2):85-90
  78. Jezova, D., Makatsori, A., Smriga, M., Morinaga, Y., and Duncko, R. Subchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety. Nutr.Neurosci. 2005;8(3):155-160
  79. Walsh DE, Griffith RS, Behforooz A. Subjective response to lysine in the therapy of herpes simplex. J Antimicrob Chemother 1983;12:489-496.
  80. McCune MA, Perry HO, Muller SA, O’Fallon WM. Treatment of recurrent herpes simplex infections with l-lysine monohydrochloride. Cutis 1984;34:366-37
  81. Tankersley RW Jr. Amino acid requirements of herpes simplex virus in human cells. J Bacteriol 1964;87:609-613.

 

 






 |